GlyCOVID

GlyCOVID is a dataset of RDFized COVID-19 data related to glycans. Resources will be added incrementally as publications are curated.

Longitudinal Development of Antibody Responses in COVID-19 Patients of Different Severity with ELISA, Peptide, and Glycan Arrays: An Immunological Case Series.
Heidepriem J, et al.
Pathogens. 2021; 10(4):438. https://doi.org/10.3390/pathogens10040438

A longitudinal analysis of three COVID-19 patients with moderate (#1) and mild disease (#2 and #3) was published. Antibody serum responses were analyzed using spike glycoprotein enzyme linked immunosorbent assay (ELISA), full-proteome peptide, and glycan microarrays. In this Glycovid dataset, the data from these glycan microarray experiments have been RDFized. Fluorescence intensity is given in arbitrary fluorescence units (AFU) as reported in this publication.

Source Last Updated
PSICQUIC March 30, 2022
Displaying entries 801 - 825 of 4050 in total
Antibody ▼ Patient Onset (days) Symptom GlyTouCan ID Arbitrary Fluorescence Units (AFU)
IgM Patient 2 3 mild
G92823JK
92
IgM Patient 2 3 mild
G93351GM
541
IgM Patient 2 3 mild
G94435QH
47
IgM Patient 2 3 mild
G94576MN
327
IgM Patient 2 3 mild
G96557TJ
119
IgM Patient 2 3 mild
G96865DJ
138
IgM Patient 2 3 mild
G96881BQ
45
IgM Patient 2 3 mild
G98068PA
170
IgM Patient 2 3 mild
G98240FC
446
IgM Patient 2 3 mild
G99603GB
267
IgM Patient 3 -180 mild
G00048MO
67
IgM Patient 3 -180 mild
G00051MO
129
IgM Patient 3 -180 mild
G00052MO
94
IgM Patient 3 -180 mild
G00053MO
63
IgM Patient 3 -180 mild
G00054MO
75
IgM Patient 3 -180 mild
G00057MO
442
IgM Patient 3 -180 mild
G00065MO
109
IgM Patient 3 -180 mild
G00066MO
235
IgM Patient 3 -180 mild
G00068MO
301
IgM Patient 3 -180 mild
G02557XE
72
IgM Patient 3 -180 mild
G02670IJ
139
IgM Patient 3 -180 mild
G03499BP
100
IgM Patient 3 -180 mild
G07483YN
102
IgM Patient 3 -180 mild
G08340FW
9975
IgM Patient 3 -180 mild
G08520NM
105

About Release Notes Help Feedback

International Collaboration

GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.

Acknowledgements

Supported by JST NBDC Grant Number JPMJND2204

Partly supported by NIH Common Fund Grant #1U01GM125267-01


Logo License Policies Site Map

Contact: support@glycosmos.org

This work is licensed under Creative Commons Attribution 4.0 International


GlyCosmos Portal v4.1.0

Last updated: December 9, 2024